Skip to main content
OpenTrials
Completed

NCT Number: NCT00184223

Motivational Interviewing to Acutely Admitted Psychiatric Patients With Comorbid Substance Use

The purpose for this study is to determine whether 2x45 minutes Motivational Interviewing given during hospital stay to acutely admitted psychiatric patients with substance use problems, can reduce substance use after discharge.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance-related Disorders Chemically-Induced Disorders Mental Disorders

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Østmarka Psychiatric Department, St. Olavs Hospital, University Hospital of Trondheim

Trondheim, Norway

About this study

The aims of the study are in a randomized controlled trial to compare the effects of 2 x 45 minutes Motivational Interviewing and standard treatment with standard treatment alone.All patients acutely admitted to Østmarka Psychiatric Hospital are evaluated for substance use, and all patients with substance use that give their consent to participate are randomized to Motivational Interviewing and standard treatment or standard treatment alone.

Substance use and function will be followed for two years.Admittances to hospital and contacts with primary health care for five years.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • substance use
  • acutely admitted to psychiatric hospital

Exclusion criteria

  • dementia
  • serious brain damage
  • not speaking Norwegian or English

Treatment and study plan

Motivational Interviewing

Behavioral

2 sessions of 45 minutes each with manual guided motivational interviewing delivered individually by a trained therapist.

Treatment as Usual

Other

Treatment as usual is individualized according to the clinical condition of the patients during the stay and in accordance with general national and international medical standards. It includes detoxification, pharmacotherapy, and general psychotherapy. Also, treatment is given for any coexisting non-substance-related disorder, including psychiatric disorders.

Primary outcomes

  1. Substance use and function questionnaire

    Time frame: 2 years

Secondary outcomes

  1. Admissions to hospital

    Time frame: 2 years

  2. Number of contacts with primary ealth care

    Time frame: 2 years

Sponsors and collaborators

Lead sponsor

Norwegian University of Science and Technology

Other

Collaborators

  • St. Olavs Hospital

Registry information

Important dates

Study start
2004
Primary completion
2005
Study completion
2005
First posted
Sep 16, 2005
Registry last updated
Jun 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.